• Applied Workflows with EZ Cap™ Cre mRNA (m1Ψ) for Gene Editi

  2026-06-19

  EZ Cap™ Cre mRNA (m1Ψ) streamlines Cre-lox gene editing with high stability and minimized immunogenicity—enabling efficient, reproducible workflows for both in vitro and in vivo applications. This guide translates cutting-edge delivery innovations into actionable protocols and troubleshooting strategies for advanced gene therapy and functional genomics.

• DMXAA (Vadimezan): Protocols and Innovations in Cancer Biolo

  2026-06-18

  DMXAA (Vadimezan) is redefining tumor vascular disruption and innate immunity research with precise, quantifiable effects on endothelial apoptosis and anti-angiogenic signaling. Explore how advanced nanorod-based delivery and optimized protocols make it a standout tool for translational cancer studies.

• Anti-ROR1 Antibody (Zilovertamab): Optimized Workflows in Li

  2026-06-18

  Harness the precision of Anti-ROR1 Antibody (Zilovertamab) for dissecting Wnt5a-induced ROR1 signaling across both oncology and toxin-driven liver injury models. This guide delivers robust, stepwise protocols, actionable troubleshooting, and cross-domain insights for maximizing reproducibility and anti-tumor efficacy.

• SERCA2 Dysfunction Drives Atherosclerosis via CaN/FoxO1/FABP

  2026-06-17

  The referenced study uncovers how SERCA2 C674S mutation-induced dysfunction accelerates atherosclerosis by activating the calcineurin/FoxO1/FABP4 axis in macrophages, promoting foam cell formation. Targeting this pathway, particularly FABP4 inhibition, ameliorates lipid accumulation, highlighting a mechanistically validated therapeutic angle for atherosclerosis research.

• Accurate Encapsulation Efficiency in Dual-Loaded Liposomes:

  2026-06-17

  This study introduces a nanoparticle exclusion chromatography (nPEC) method for accurately determining encapsulation efficiency in dual-loaded liposomes, overcoming challenges associated with co-encapsulating hydrophilic and lipophilic drugs. The findings enable more reliable drug delivery research and protocol optimization, especially for compounds like oleanolic acid relevant to immune modulation and antiviral strategies.

• Asunaprevir (BMS-650032): Advancing HCV Protease Inhibition

  2026-06-16

  Asunaprevir (BMS-650032) empowers researchers to dissect hepatitis C virus (HCV) replication across all major genotypes, offering nanomolar potency and high selectivity. This guide delivers evidence-based protocols, troubleshooting insights, and advanced workflow tips to unlock the full translational potential of this trusted APExBIO antiviral agent.

• GSK621: Potent AMPK Agonist for Metabolic and AML Research

  2026-06-16

  GSK621 stands out as a potent, highly selective AMPK agonist, empowering researchers to dissect metabolic reprogramming, apoptosis, and autophagy in acute myeloid leukemia and immunometabolic models. This article delivers actionable protocols, troubleshooting strategies, and practical insights inspired by cutting-edge research and real-world workflows.

• Micropeptide MRPIP Regulates Mitochondrial RNA in HCC Progre

  2026-06-15

  Zhu et al. present a proteomic analysis identifying HCC-associated micropeptides, with a focus on MRPIP—a peptide that disrupts mitochondrial RNA processing, impairs energy production, and suppresses tumor growth. The study provides mechanistic insight into how micropeptides can function as tumor suppressors in hepatocellular carcinoma.

• Injectable GelMA/QCS/Ca2+ Adhesive for Rapid Hemostasis and

  2026-06-15

  The referenced study introduces an injectable multifunctional hemostatic adhesive combining GelMA, quaternary ammonium chitosan, and calcium ions. This innovation addresses rapid hemostasis and antibacterial protection in non-compressible hemorrhage, showing superior performance over commercial fibrin glues in preclinical models.

• Strategic Buffering in Translational Research: Na2HPO4 Insig

  2026-06-14

  Sodium phosphate dibasic (Na2HPO4) sits at the crossroads of biochemical precision and translational impact, underpinning reliable data from molecular assays to complex environmental toxicology studies. This article dissects its mechanistic utility, integrates protocol-level guidance, and frames its strategic value for researchers navigating reproducibility and ecological stewardship. We bridge rigorous aquatic toxicity evidence with best practices in buffer design, referencing both APExBIO’s benchmark offering and key literature to escalate the discourse beyond conventional product summaries.

• Okadaic acid (A4540): Practical Guidance for PP1 Inhibition

  2026-06-13

  Okadaic acid is a potent, selective inhibitor of protein phosphatase 1 (PP1) and 2A (PP2A), used to dissect phosphorylation-dependent signaling and apoptosis in cell and biochemical studies. It is best employed in workflows where specific and reversible phosphatase inhibition is required, but is not suitable for broad-spectrum phosphatase inhibition or contexts where off-target effects cannot be tightly controlled.

• Intestinal TM6SF2 Modulates Gut–Liver Axis in MASH Pathogene

  2026-06-12

  This study reveals that intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis (MASH) by regulating gut barrier integrity, microbial composition, and signaling to the liver. The findings position the intestinal TM6SF2–LPA pathway as a critical therapeutic target for MASH, with implications for preclinical modeling of gut–liver immune interactions.

• Applied Use of Cy3 Goat Anti-Rabbit IgG (H+L) Antibody in Ad

  2026-06-12

  The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody from APExBIO delivers robust, amplified fluorescent detection for immunofluorescence, immunohistochemistry, and flow cytometry. This article breaks down optimized workflows, troubleshooting strategies, and practical insights—bridging recent advances in stem cell inflammation models with day-to-day lab performance.

• LG 101506 (RXR Modulator): Workflow Optimization in RXR Rese

  2026-06-11

  LG 101506, a precision RXR modulator from APExBIO, streamlines nuclear receptor signaling studies with unmatched purity and workflow adaptability. This guide bridges breakthrough immunotherapy findings with hands-on experimental design, offering actionable troubleshooting and advanced assay enhancements for RXR pathway research.

• HyperScript III RT SuperMix: Precision qPCR for CRC Subtypin

  2026-06-11

  HyperScript III RT SuperMix enables robust, high-fidelity cDNA synthesis from challenging RNA samples, supporting quantitative gene expression profiling even in low-copy or high-GC contexts. Its integrated genomic DNA wiper ensures accurate qPCR results, making it a critical tool for translational oncology workflows and precision biomarker validation.

449 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page